Core Scientific Reports Warrant Exercises
Ticker: CORZR · Form: 8-K · Filed: Feb 5, 2025 · CIK: 1839341
| Field | Detail |
|---|---|
| Company | Core Scientific, Inc./Tx (CORZR) |
| Form Type | 8-K |
| Filed Date | Feb 5, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $6.81, $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: warrants, filing, disclosure
TL;DR
Core Scientific's warrants exercised Feb 5, 2025 - could mean cash infusion or more shares.
AI Summary
On February 5, 2025, Core Scientific, Inc. filed an 8-K report detailing the exercise of warrants. The filing indicates that warrants with an exercise price of $6.81 per share and $0.01 per share were exercised on this date. This action suggests potential capital infusion or share issuance related to these warrant exercises.
Why It Matters
The exercise of warrants can indicate investor confidence and potentially lead to an increase in the company's cash reserves or outstanding shares.
Risk Assessment
Risk Level: medium — Warrant exercises can impact share count and company financials, requiring careful monitoring.
Key Numbers
- $6.81 — Warrant Exercise Price (One of the exercise prices reported for warrants on Feb 5, 2025.)
- $0.01 — Warrant Exercise Price (Another exercise price reported for warrants on Feb 5, 2025.)
Key Players & Entities
- Core Scientific, Inc. (company) — Registrant
- February 5, 2025 (date) — Date of Report
- $6.81 (dollar_amount) — Warrant Exercise Price
- $0.01 (dollar_amount) — Warrant Exercise Price
- Power & Digital Infrastructure Acquisition Corp. (company) — Former Company Name
FAQ
What is the total number of shares issued upon the exercise of these warrants?
The filing does not specify the number of shares issued, only the exercise prices of the warrants exercised on February 5, 2025.
What was the total cash proceeds received by Core Scientific from these warrant exercises?
The filing does not provide the total cash proceeds, only the exercise prices of $6.81 and $0.01 per share.
Were these warrants exercised by management, employees, or external investors?
The filing does not disclose the identity of the warrant holders who exercised their options.
Does the exercise of these warrants trigger any other reporting requirements for Core Scientific?
The filing itself is the primary reporting event for the warrant exercise under Regulation FD and financial statement disclosures.
What is the significance of the two different exercise prices ($6.81 and $0.01)?
The filing indicates two distinct series of warrants were exercised, each with its own specified exercise price.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-02-05 16:02:58
Key Financial Figures
- $0.00001 — ich registered Common stock, par value $0.00001 per share CORZ The Nasdaq Global Selec
- $6.81 — of common stock at an exercise price of $6.81 per share CORZW The Nasdaq Global Sel
- $0.01 — of common stock at an exercise price of $0.01 per share CORZZ The Nasdaq Global Sel
Filing Documents
- core-20250205.htm (8-K) — 35KB
- finalf1draftjan25productio.htm (EX-99.1) — 35KB
- image_0.jpg (GRAPHIC) — 5KB
- image_1.jpg (GRAPHIC) — 3KB
- image_2.jpg (GRAPHIC) — 6KB
- image_3.jpg (GRAPHIC) — 42KB
- 0001628280-25-004016.txt ( ) — 329KB
- core-20250205.xsd (EX-101.SCH) — 3KB
- core-20250205_def.xml (EX-101.DEF) — 17KB
- core-20250205_lab.xml (EX-101.LAB) — 30KB
- core-20250205_pre.xml (EX-101.PRE) — 17KB
- core-20250205_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On February 5, 2025, the Company issued a press release announcing certain production and operations updates for the month of January 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated into this Item 7.01 by reference. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language except as expressly set forth by specific reference in such filing.
01 Financial Statement and Exhibits
Item 9.01 Financial Statement and Exhibits (d) Exhibits: Exhibit No. Description 99.1 Press Release dated February 5 , 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Scientific, Inc. Dated: February 5, 2025 By: /s/ Todd M. DuChene Name: Todd M. DuChene Title: Chief Legal Officer and Chief Administrative Officer